Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Functional Brain Connectivity Studies, and Medical Imaging Techniques and Applications.
Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
Plasma p‐tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10‐year window
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex
The impact of kidney function on Alzheimer’s disease blood biomarkers: implications for predicting amyloid-β positivity
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease
Temporal Dynamics and Biological Variability of Alzheimer Biomarkers
Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration
The landscape of autosomal-dominant Alzheimer’s disease: global distribution and age of onset
Exploring inflammation‐related protein expression and its relationship with TSPO PET in Alzheimer's disease
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease
Connectivity as a universal predictor of tau progression in atypical Alzheimer’s disease
Quantitative MRI of the hippocampus reveals microstructural trajectories of aging and Alzheimer’s disease pathology
Equivalence of the FCSRT and RAVLT to detect medial Temporal lobe atrophy and tauopathy
Translating the Post-Mortem Brain Multi-Omics Molecular Taxonomy of Alzheimer’s Dementia to Living Humans
Multiclass Epilepsy Classification Using Radiomics Features From T1-Weighted MRI
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings
Atrophy network mapping of clinical subtypes and main symptoms in frontotemporal dementia
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
Neuromodulatory subcortical nucleus integrity is associated with white matter microstructure, tauopathy and APOE status
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease